I-Tech AB (ITECH.ST) Research

I-Tech AB, a biotechnology firm established in Mölndal, Sweden, in 2000, focuses on creating and commercializing products to prevent biofouling. Their flagship innovation is Selektope, a unique bio-repellent ingredient engineered for marine coatings. This compound provides crucial protection against hard fouling on ships, primarily by temporarily stimulating the swimming behavior of barnacle larvae, thereby preventing them from attaching to coated surfaces. The company's primary clientele is the marine coatings industry.

Market snapshot

Symbol
ITECH.ST
Price
$70.00
Day change
+1.89%
Market cap
$839.8M
P/E ratio
24.14x
52-week range
42.2-124.5
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 months

Peer companies

  • Cantargia AB (publ) (CANTA.ST)
  • C-Rad AB (publ) (CRAD-B.ST)
  • Diamyd Medical AB (publ) (DMYD-B.ST)
  • Genovis AB (publ.) (GENO.ST)
  • Infant Bacterial Therapeutics AB (publ) (IBT-B.ST)
  • Oncopeptides AB (publ) (ONCO.ST)
  • Orexo AB (publ) (ORX.ST)
  • Sedana Medical AB (publ) (SEDANA.ST)

Open I-Tech AB (ITECH.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.